Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672737 · ClinicalTrials.gov registry record
Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 56
- Enrollment target
NCT00672737: Completed study, sponsored by Stanford University.
NCT00672737 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672737 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
We would like to test the effect of opioid medication on pain sensitivity in subjects who have been diagnosed with a sleep disorder called Obstructive Sleep Apnea (OSA) compared to other subjects without OSA. Patients with OSA may have an altered sensitivity to the sedative, analgesic, and respiratory depressant effects of opioids.
Interventions
- DRUG Remifentanil
- PROCEDURE Polysomnography
- PROCEDURE Cold pain threshold and tolerance
- DEVICE Heat pain threshold and tolerance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00672737
The ClinicalTrials.gov registry entry for NCT00672737 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Remifentanil is the first listed.
NCT00672737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00672737 about?
NCT00672737 is a clinical study titled "Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea". We would like to test the effect of opioid medication on pain sensitivity in subjects who have been diagnosed with a sleep disorder called Obstructive Sleep Apnea (OSA) compared to other subjects without OSA. Patients with OSA may have an altered sensitivity to the sedative, analgesic, and respirato...
What is the current status of trial NCT00672737?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2008-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00672737?
The interventions under investigation include: Remifentanil (DRUG), Polysomnography (PROCEDURE), Cold pain threshold and tolerance (PROCEDURE), Heat pain threshold and tolerance (DEVICE).
Who is sponsoring clinical trial NCT00672737?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.